An Investigational Scan (Zirconium Zr 89-Df-crefmirlimab PET) to Study the Effect of Radiation Therapy on CD8 Positive T Cells

An Investigational Scan (Zirconium Zr 89-Df-crefmirlimab PET) to Study the Effect of Radiation Therapy on CD8 Positive T Cells
Condition:   Metastatic Malignant Solid Neoplasm
Interventions:   Procedure: Positron Emission Tomography;   Radiation: Stereotactic Body Radiation Therapy;   Drug: Zirconium Zr 89-Df-Crefmirlimab
Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 13, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments